EIF6 and leukemia: We cloned patient-derived mutations with different predicted functional consequences and generated K562 leukemia cell lines that expressed wild-type or mutant EIF6 cDNA with a C-terminal V5-epitope tag under the control of a doxycycline-inducible promoter.